Lobbying client
CURE PHARMACEUTICALS
Pharmaceutical Manufacturer and Creator
Filings
5
Filed by
1
Reported in-house
—
Reported by firms
—
Filings
5 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Termination Amendment 4th Quarter 2013
|
SMITH GARSON | — reported |
|
3rd Quarter - Amendment 3rd Quarter 2013
|
SMITH GARSON | — reported |
|
2nd Quarter - Amendment 2nd Quarter 2013
|
SMITH GARSON | — reported |
|
Registration - Amendment 2nd Quarter 2013
|
SMITH GARSON | — reported |
|
Registration 4th Quarter 2012
|
SMITH GARSON | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| SMITH GARSON | 3 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Pharmacy | PHA | 5 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.